Evaluation of galectin-3 and ferritin with liver enzymes in women with breast cancer

Abstract

Cancer, as we know it, refers to more than a hundred different types of malignant tumors that can be found in various tissues throughout the body., including breast cancer. Breast cancer is a life-threatening condition that can have a negative impact on women's self-esteem. The most frequent cancer is breast cancer non-skin malignant tumor and is a type of cancerous tumor that occurs in breast tissue. The current study involved evaluation the level of Galectin-3 and ferritin with liver enzymes in breast cancer women. The study contained the collection of 90 blood samples for women, and the samples were divided into 50 samples for women with breast cancer, their ages ranged from 40-70 years, the samples were collected from the Breast Cancer Center in Baquba General Hospital, and 40 blood samples for healthy women as a control group, and their same ages, during the period from the beginning of October 2021 until the end of December 2021. The findings revealed a considerable rise in the level of Galectin-3 in breast cancer women compared to healthy women.